The joint statement issued last week, said that the team of scientists from the Center for Structural Genomics of Infectious Diseases (CSGID) and Structural Genomics Center for Infectious diseases Seattle (SSGCID) worked in the direction towards this goal since 2007. Joint team now includes a total of more than 200 scientists.
Their work is funded by the five-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), which, in turn, is part of the National Institutes of Health in the United States (NIH).
Dr. Wayne Anderson, a professor of molecular pharmacology and biological chemistry at Northwestern University Feinberg School of Medicine in Chicago, headed CSGID, an international consortium, which includes research centers in the US, UK and Canada. In a media interview, he said that:
"Determining protein structures can help researchers find potential targets for new therapeutic drugs, essential enzymes, and possible candidates for vaccines against deadly diseases known."